Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Remicade receives E.U. approval for Crohn's disease treatment

Aug. 19, 1999

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Aug. 16, 1999

FDA approves injectable, oral formulations of Wyeth-Ayerst's Protonix

Aug. 6, 1999

Anti-H. pylori agents isolated from natural source by Takeda team

Aug. 6, 1999

Zeffix approved in E.U. for chronic HBV

Aug. 3, 1999

PA153, a novel agent for the diagnosis and treatment of pancreatic diseases

Aug. 3, 1999

Structurally novel 5-HT3 receptor antagonist characterized in vitro and in vivo

July 30, 1999

Enzo Biochem begins human trial for HBV therapy

July 30, 1999

No adverse influence on cardiac repolarization seen in in vitro studies with tegaserod

July 29, 1999

Schering-Plough launches Rebetol combination therapy in the U.K.

July 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...